Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Prevalence of low bone mass in individuals with HIV infection
Journal Information
Vol. 157. Issue 5.
Pages 234-237 (September 2021)
Share
Share
Download PDF
More article options
ePub
Visits
0
Vol. 157. Issue 5.
Pages 234-237 (September 2021)
Brief report
Prevalence of low bone mass in individuals with HIV infection
Prevalencia de baja masa ósea en pacientes con infección por VIH
Visits
...
Pilar Vizcarraa,
Corresponding author
pilar1vizcarra@gmail.com

Corresponding author.
, Juan Gallegoa, Cristina Sobrinob, Walter A. Sifuentesb, María J. Vivancosa, José L. Casadoa
a Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, Madrid, Spain
b Servicio de Reumatología, Hospital Universitario Ramón y Cajal, Madrid, Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (2)
Table 1. Prevalence of osteopenia and osteoporosis in the lumbar spine and femoral neck in men according to age group.
Table 2. Prevalence of osteopenia and osteoporosis in the lumbar spine and femoral neck in women according to age group.
Show moreShow less
Abstract
Background and aims

There are no population data on bone mass in individuals with HIV in Spain, adjusted for age and sex.

Materials and methods

Bone mineral density (BMD) data were obtained by dual X-ray absorptiometry in a cohort of individuals with HIV infection compared with cohort data from the general population in Spain and the United States of America.

Results

Of 928 individuals (mean 46 years, 25% women), the prevalence of osteoporosis in the lumbar spine/femoral neck was 18%/5% in men, and 17%/10% in women, respectively. The rate increased from the age of 40 in men and from 50 in women (osteoporosis in 20% and 27%, respectively). BMD was lower than that observed in the general population in almost all age groups (mean, -6%; between 0%–11% lower compared to the Spanish cohort, and -8%; between 0%–14% lower than the American cohort).

Conclusions

Our cohort of individuals with HIV had a lower BMD in all age groups after adjustment for age and sex, compared with the general population. This fact must be considered when making recommendations.

Keywords:
HIV infection
Osteoporosis
Bone mineral density
Resumen
Antecedentes y objetivo

No existen datos poblacionales de masa ósea en pacientes con VIH en España, ajustados por edad y sexo.

Materiales y métodos

Se recogieron los datos de densidad mineral ósea (DMO) mediante absorciometría dual de rayos X en una cohorte de pacientes con infección por VIH, comparándose con los valores observados en cohortes de población general españolas y estadounidenses.

Resultados

En 928 pacientes (media 46 años, 25% mujeres), la prevalencia de osteoporosis en columna lumbar/cuello femoral fue del 18/5% en varones, y 17/10% en mujeres, respectivamente, aumentando desde los 40 años en varones y desde los 50 años en mujeres (osteoporosis en 20 y 27%, respectivamente). La DMO fue inferior a la observada en la población general en casi todos los grupos etarios (media, -6%; entre 0–11% inferior respecto a la cohorte española, y -8%; entre 0–14% inferior a la estadounidense).

Conclusiones

Nuestra cohorte de pacientes con VIH tiene una menor DMO en todos los grupos etarios ajustados por edad y sexo, en comparación con la población general. Este hecho debe ser considerado en las recomendaciones de manejo.

Palabras clave:
Infección por VIH
Osteoporosis
Densidad mineral ósea

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos